PATIENTS WITH RELAPSING ANCA-ASSOCIATED VASCULITIS (AAV) EXPERIENCE UNMET NEEDS AND UTILISE SIGNIFICANT HEALTHCARE RESOURCES

被引：0
|
作者：
Spearpoint, P. [1 ]
Goette, D. [1 ]
Chaussy, J. [1 ]
Rutherford, P. [1 ]
机构：
[1] Vifor Pharma, Glattbrugg, Switzerland
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY5
引用
收藏
页码：S436 / S436
页数：1
相关论文
共 50 条
  • [21] Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist
    Lee, Jennifer J. Y.
    Alsaleem, Alhanouf
    Chiang, Grace P. K.
    Limenis, Elizaveta
    Sontichai, Watchareewan
    Yeung, Rae S. M.
    Akikusa, Jonathan
    Laxer, Ronald M.
    PEDIATRIC RHEUMATOLOGY, 2019, 17 (1)
  • [22] EFFECTS OF PSYCHOLOGICAL STRESS ON ANCA-ASSOCIATED VASCULITIS (AAV) DIAGNOSIS
    Jain, Koyal
    Falk, Ronald
    Hogan, Susan
    RHEUMATOLOGY, 2019, 58
  • [23] Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist
    Jennifer J. Y. Lee
    Alhanouf Alsaleem
    Grace P. K. Chiang
    Elizaveta Limenis
    Watchareewan Sontichai
    Rae S. M. Yeung
    Jonathan Akikusa
    Ronald M. Laxer
    Pediatric Rheumatology, 17
  • [24] Avacopan for Patients with ANCA-associated Vasculitis
    Rauen, Thomas
    Kraemer, Stefan
    Floege, Juergen
    NEPHROLOGIE, 2022, 17 (02): : 117 - 118
  • [25] Early Experience with Avacopan for ANCA-Associated Vasculitis in a Large Integrated Healthcare System
    Srivatsan, Shruthi
    Williams, Zachary
    Cook, Claire
    Fu, Xiaoqing
    Patel, Naomi
    Wallace, Zachary
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1711 - 1712
  • [26] Rituximab for ANCA-associated vasculitis: The UK experience
    Jayne, David
    PRESSE MEDICALE, 2013, 42 (04): : 532 - 534
  • [27] ANCA-ASSOCIATED VASCULITIS IN PATIENTS WITH SLE
    Ziauddin, O.
    Levine, J.
    Cedillo-Couvert, E.
    Setty, S.
    Arami, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (04) : 873 - 874
  • [28] Morbidity in patients with ANCA-associated vasculitis
    Harper, Lorraine
    PRESSE MEDICALE, 2013, 42 (04): : 612 - 616
  • [29] SIGNIFICANT BURDEN OF DISEASE DURING MAINTENANCE TREATMENT OF ANCA-ASSOCIATED VASCULITIS (AAV) PATIENTS IN REAL WORLD PRACTICE IN EUROPE
    Rutherford, Peter
    Gotte, Dieter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 718 - 718
  • [30] Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis
    Haubitz, M
    Koch, KM
    Brunkhorst, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (08) : 2074 - 2076
12345